AAN: American Academy of Neurology
American Academy of Neurology (AAN): Annual Meeting
Conference Coverage
Sleep apnea is linked with tau accumulation in the brain
Philadelphia – Study results suggest a mechanism for the observed association between sleep disruption and increased...
Conference Coverage
Medical cannabis relieved pain, decreased opioid use in elderly
Medical cannabis was an effective and well-tolerated treatment in an elderly cohort of patients with chronic pain.
Conference Coverage
Is pro soccer a risk factor for ALS?
A higher risk of ALS and an earlier age of onset was found among professional soccer players.
Conference Coverage
Does BMI affect outcomes after ischemic stroke?
Overweight and obese patients have greater survival and less risk of disability after acute ischemic stroke, according to an analysis of the FAST-...
Conference Coverage
Serum Nf-L shows promise as biomarker for BMT response in MS
An analysis of paired samples suggests a valuable role for serum Nf-L in predicting MS severity and treatment response.
Conference Coverage
Novel cEEG-based scoring system predicts inpatient seizure risk
LOS ANGELES – A validation study is currently underway on use of the 2HELPS2B scoring system to predict seizures in acutely ill hospitalized...
Conference Coverage
Fitbit Flex is feasible, provides nuanced step count data in MS patients
Conference Coverage
Midlife retinopathy predicts ischemic stroke
LOS ANGELES – No tie to hemorrhagic strokes observed in review of more than 10,000 patients followed for nearly 20 years.
Conference Coverage
Value of alemtuzumab demonstrated in RRMS patients with prior IFNB-1a treatment
CARE-MS II extension data suggest that alemtuzumab provides a unique treatment approach for relapsing-remitting multiple sclerosis patients with...
Conference Coverage
Sulforaphane for autism? Maybe
LOS ANGELES –The dietary supplement is showing benefit in a small, ongoing trial, but there are a lot of pills.
Conference Coverage
Ocrelizumab safety update: Encouraging rates of serious infection, malignancy
No new safety signals were seen in the latest update from studies and postmarketing surveillance of MS patients treated with ocrelizumab.
Conference Coverage
Myelin antibody predicts ADEM relapse
LOS ANGELES – Could results help to guide decisions on immunosuppressive treatment?
Conference Coverage
Guidance coming for mTOR inhibitors in infantile TSC
LOS ANGELES – Survey aimed to describe the wide variation in their off-label use, particularly in infants.
Conference Coverage
Parkinson’s disease patients have impaired insulin secretion
LOS ANGELES – Blood glucose dysregulation should be screened in Parkinson’s disease patients with moderate to advanced disease.
Conference Coverage
Interferon treatment does not increase stroke risk in MS
Pooled data from 17 trials, as well as postmarketing surveillance data, show no increase in stroke risk with interferon treatment in MS patients...